Skip to content

A Mobile App to Help Monitor Chemotherapy Side Effects in Children with Leukemia

Validation of a Caregiver assisted mobile health application for monitoring chemotherapy related symptoms in children with Acute lymphoblastic leukemia at a tertiary care Centre, Mumbai- A feasibility study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112768
Enrollment
30
Registered
2026-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Caregivers or pediatric patients between the age group of 7 to 15 years diagnosed with ALL cancer undergoing chemotherapy. 2. Caregivers or pediatric patients who are willing to provide consent to participate in the study. 3. Caregivers or children who are able to use the mobile application and communicate in English,

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Pediatric patients diagnosed with cancers other than ALL. 2. Pediatric patients diagnosed with ALL not in active chemotherapy treatment. 3. Pediatric patients who are admitted due to severity of symptoms, hence unable to use the mobile health application

Design outcomes

Primary

MeasureTime frame
Outcome Measures Primary outcomes include: App adherence rate (percentage of days with complete symptom entries) Accuracy and consistency of symptom data compared with clinical documentation User satisfaction score among caregivers and patients Secondary outcomes assess feasibility and usability of the mobile health application for future clinical integration and larger validation trials at TM H Timepoint: daily basis for 30 consecutive days

Secondary

MeasureTime frame
Secondary outcomes assess feasibility and usability of the mobile health application for future clinical integration and larger validation trials at TM H Timepoint: daily basis for 30 consecutive days

Countries

India

Contacts

Public ContactMs. Beena Varghese

Tata Memorial Hospital, HBNI University

manisha.19pawar@gmail.com7738059723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026